Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0000947871-18-000492

Director sold 18,700 shares at an average $13.56 ($253,631)

From the SEC's structured data for this filing

Trades in this filing

ORBIMED ADVISORS LLC · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-06-04 Sale : show line 1 in the form −17,100 $13.57 $232,047 4,902,910 I
2018-06-06 Sale : show line 2 in the form −1,600 $13.49 $21,584 4,901,310 I
Open-market sales · 18,700 sh · avg $13.56 · $253,631
Loading xslF345X03/ss95078_4.xml…